Protocols for High-Risk Pregnancies: An Evidence-Based Approach
Description:
High-risk pregnancies present life-threatening challenges to two of your patients: the mother and her fetus. The direct, exemplary guidance in Protocols for High-Risk Pregnancy enables you to
- better understand your patients' conditions
- devise optimum management strategies
- maximize the outcome and minimize the complications for both the mother and her fetus
To enhance clinical relevance, each protocol is written as if the patient were present. Evidence to support an intervention is given where it exists. The authors' experience provides additional wise counsel. Key references provide the springboard for a deeper understanding of a topic. In this more compact and fully updated sixth edition, new protocols include
- Amniotic fluid disorders
- Depression
- Fetal growth restriction
- HIV
- Indicated late preterm and early term birth
- Malaria
- Noninvasive prenatal diagnosis
Designed for clinical practice by the leaders of two generations of maternal-fetal medicine, no obstetrician or obstetric health care provider can afford to miss Protocols for High-Risk Pregnancy.
Best prices to buy, sell, or rent ISBN 9781119000877
Frequently Asked Questions about Protocols for High-Risk Pregnancies: An Evidence-Based Approach
The price for the book starts from $22.69 on Amazon and is available from 11 sellers at the moment.
If you’re interested in selling back the Protocols for High-Risk Pregnancies: An Evidence-Based Approach book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Protocols for High-Risk Pregnancies: An Evidence-Based Approach book, the best buyback offer comes from and is $ for the book in good condition.
The Protocols for High-Risk Pregnancies: An Evidence-Based Approach book is in very low demand now as the rank for the book is 3,618,072 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.